CRIP1 and thyroid gland carcinoma: Aberrant expression of CRIP1 was also mentioned in several tumor types including prostate cancer, pancreatic caner, cervical cancer, breast cancer, osteosarcoma, gastric cancer, and thyroid cancer [7–13].